Currently browsing: Items authored or edited by Farah Huzair

Robbins, Peter and Huzair, Farah eds. (2011). Exploring Central And Eastern Europe's Biotechnology Landscape. The International Library of Ethics Law and Technology, 9. Dordrecht: Springer.

Huzair, Farah and Robbins, Peter (2011). Human life science and agricultural biotechnology in transition: an introduction. In: Robbins, Peter and Huzair, Farah eds. Exploring Central and Eastern Europe's Biotechnology Landscape. The International Library of Ethics, Law and Technology, 9. Dordrecht: Springer, pp. 1–11.

Huzair, Farah (2011). Coping Strategies and System Adaptation of Agricultural Biotechnology Research in Hungary. In: Robbins, Peter T. and Huzair, Farah eds. Exploring Central and Eastern Europe's Biotechnology Landscape. The International Library of Ethics, Law and Technology (9). Dordrecht: Springer, pp. 157–176.

Robbins, Peter and Huzair, Farah (2011). Final remarks. In: Robbins, Peter and Huzair, Farah eds. Exploring Central and Eastern Europe's Biotechnology Landscape. The International Library of Ethics, Law and Technology, 9. Dordrecht: Springer, pp. 201–220.

Nemes, Gustav; High, Chris and Huzair, Farah (2006). Reflexive agency and multi-level governance: mediating integrated rural development in South Transdanubia. In: Cheshire, L.; Higgins, V. and Lawrence, G. eds. Rural Governance: International perspectives. Routledge Studies in Human Geography. London, UK: Routledge, pp. 98–115.

Kale, Dinar and Huzair, Farah (2017). Heterogeneity in learning processes and the evolution of dynamic managerial capabilities as a response of emergence of biosimilar market: evidence from the Indian pharmaceutical industry. Technology Analysis and Strategic Management, 29(3) pp. 300–312.

• Download Accepted Manuscript (PDF / 619kB)

Huzair, Farah and Kale, Dinar (2015). Biosimilars and the long game. Trends in Biotechnology, 33(5) pp. 250–252.

• Published Version (PDF) This file is not available for public download

Dove, Edward S.; Barlas, İ. Ömer; Birch, Kean; Boehme, Catharina; Borda-Rodriguez, Alexander; Byne, William M.; Chaverneff, Florence; Coşkun, Yavuz; Dahl, Marja-Liisa; Dereli, Türkay; Diwakar, Shyam; Elbeyli, Levent; Endrenyi, Laszlo; Eroğlu-Kesim, Belgin; Ferguson, Lynnette R.; Güngör, Kıvanç; Gürsoy, Ulvi; Hekim, Nezih; Huzair, Farah; Kaushik, Kabeer; Kickbusch, Ilona; Kıroğlu, Olcay; Kolker, Eugene; Könönen, Eija; Lin, Biaoyang; Llerena, Adrian; Malhan, Faruk; Nair, Bipin; Patrinos, George P.; Şardaş, Semra; Sert, Özlem; Srivastava, Sanjeeva; Steuten, Lotte M.G.; Toraman, Cengiz; Vayena, Effy; Wang, Wei; Warnich, Louise and Özdemir, Vural (2015). An appeal to the global health community for a tripartite innovation: an ‘‘Essential Diagnostics List,’’ ‘‘Health in All Policies,’’ and ‘‘See-Through 21st Century Science and Ethics". OMICS: A Journal of Integrative Biology, 19(8) pp. 435–442.

• Download Accepted Manuscript (PDF / 239kB)

Ozdemir, Vural; Borda-Rodriguez, Alexander; Dove, Edward S; Ferguson, Lynette R; Huzair, Farah; Manolopoulos, Vangelis G.; Masellis, Mario; Milius, Djims; Warnich, Louise and Srivastava, Sanjeeva (2013). Editorial: public health pharmacogenomics and the design principles for global public goods – moving genomics to responsible innovation. Current Pharmacogenomics and Personalized Medicine, 11(1) pp. 1–4.

• Download Published Version (PDF / 48kB)

Huzair, Farah; Borda-Rodriguez, Alexander; Upton, Mary and Mugwagwa, Julius (2013). An interdisciplinary and development lens on knowledge translation. Science and Public Policy, 40(1) pp. 43–50.

Huzair, Farah and Borda-Rodriguez, Alexander (2012). Challenges for the application and development of omics health technologies in developing countries. Drug Development Research, 73(7) pp. 447–451.

Manamperi, Aresha and Huzair, Farah (2012). Capacity building in genomics medicine and molecular diagnostics: the case of Sri Lanka. Current Pharmacogenomics and Personalized Medicine, 10(3) pp. 185–194.

Huzair, Farah and Papaioannou, Theo (2012). UK Biobank: consequences for commons and innovation. Science and Public Policy, 39(4) pp. 500–512.

Graham, Janice E.; Borda-Rodriguez, Alexander; Huzair, Farah and Zinck, Emily (2012). Capacity for a global vaccine safety system: the perspective of national regulatory authorities. Vaccine, 30 pp. 4953–4959.

Huzair, Farah (2012). The influenza vaccine innovation system and lessons for PDPs. Human Vaccines & Immunotherapeutics, 8(3) pp. 407–410.

Borda-Rodriguez, Alexander and Huzair, Farah (2011). Revisiting the Paris Declaration: pharmacogenomics and personalized medicine as accelerators for development aid and effectiveness. Current Pharmacogenomics and Personalized Medicine, 9(4) pp. 240–242.

• Request a copy from the author This file is not available for public download

Ngueng-Feze, Ida; Borda-Rodriguez, Alexander and Huzair, Farah (2011). Not so simple: situating postgenomics personalized medicine in the regional context in Africa for global and women's health. Current Pharmacogenomics and Personalized Medicine, 9(4) pp. 332–334.

Huzair, Farah; Borda-Rodriguez, Alexander and Upton, Mary (2011). Twenty-first century vaccinomics innovation systems: capacity building in the global South and the role of Product Development Partnerships (PDPs). OMICS: A Journal of Integrative Biology, 15(9) pp. 539–543.

• Download Accepted Manuscript (PDF / 111kB)

Huzair, Farah (2008). Innovative Potential in Hungarian Agricultural Biotechnology and the Evolution of Networks. Studies in Ethics, Law and Technology, 2(2), article no. 3.

Huzair, Farah and Robbins, Peter (2008). Life Sciences Innovation in Central and Eastern Europe: Conceptual Frameworks and Contributions. Studies in Ethics, Law and Technology, 2(2)

Robbins, Peter and Huzair, Farah (2008). Innovation in Central and Eastern Europe: An Editorial. Studies in Ethics, Law and Technology, 2(2)

• Published Version (PDF) This file is not available for public download

Kale, Dinar and Huzair, Farah (2015). New sources of growth under the TRIPS compliant patent regime for emerging country pharmaceutical industries?: Investigating the development of biosimilar capabilities in the Indian pharmaceutical sector. In: 13th Globelics International Conference, 23-25 Sep 2015, Havana, Cuba.

Kale, Dinar and Huzair, Farah (2015). Heterogeneity in learning processes and the evolution of dynamic capabilities: evidence from the Indian pharmaceutical industry. In: DRUID15 Conference on the Relevance of Innovation, 15-17 Jun 2015, Rome, Italy.

Kale, Dinar and Huzair, Farah (2014). Reconfiguration of competencies as a response to the emergence of disruptive new markets – evidence from Indian pharmaceutical firms. In: The International Joseph Schumpeter Society 15th ISS Conference: Foundations of Economic Change - Behaviour, Interaction and Aggregate Outcomes, 27-30 Jul 2014, Jena, Germany.

• Download Accepted Manuscript (PDF / 479kB)

Huzair, Farah (2008). Innovative Capabilities of the Agricultural Biotechnology Sector in Hungary. PhD thesis The Open University.

• Download Published Version (PDF / 15MB)

Graham, Janice E.; Borda-Rodriguez, Alexander and Huzair, Farah (2012). Global vaccine safety blueprint: the landscape analysis (survey of regulators). World Health Organization, Geneva.

• Download Published Version (PDF / 2MB)

Huzair, Farah and Kale, Dinar (2011). Emergence of the Biosimilar Sector and Opportunities of Developing Country Suppliers. Innogen.

• Download Published Version (PDF / 347kB)

Huzair, Farah (2006). The regulation of agricultural biotechnology in Poland and the obstacles to EU compliance. IKD, Milton Keynes, UK.

• Download Published Version (PDF / 70kB)